|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Department of Nutrition, Harvard School of Public Health, Boston (MKJ, PK-B, FBH, MF, LS, and EBR); the Centre for Alcohol Research, National Institute of Public Health, Copenhagen (MKJ and MG); the Department of Preventive Medicine, The University of Tennessee Health Science Center, Memphis (PK-B); the Department of Epidemiology, Harvard School of Public Health, Boston (FBH and EBR); and the Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston (FBH and EBR)
See corresponding editorial on page 1459
2 Supported by research grants HL35464 and CA55075 from the National Institutes of Health and a scholarship from the Danish Research Foundation (to MKJ). The Kellogg Company provided unrestricted funding of the development of the whole-grain database.
3 Reprints not available. Address correspondence to EB Rimm, Department of Nutrition, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115. E-mail: erimm{at}hsph.harvard.edu.
| ABSTRACT |
|---|
|
|
|---|
Objective: The objective was to evaluate the association of whole-grain, bran, and germ intakes (with the use of new quantitative measures) with the incidence of CHD.
Design: This was a prospective cohort study of 42 850 male health professionals aged 4075 y at baseline in 1986 who were free from cardiovascular disease, cancer, and diabetes. Daily whole-grain, bran, and germ intakes were derived in grams per day from a detailed semiquantitative dietary questionnaire.
Results: During 14 y of follow-up, we documented 1818 incident cases of CHD. After cardiovascular disease risk factors and the intakes of bran and germ added to foods were controlled for, the hazard ratio of CHD between extreme quintiles of whole-grain intake was 0.82 (95% CI: 0.70, 0.96; P for trend = 0.01). The hazard ratio of CHD in men with the highest intake of added bran was 0.70 (95% CI: 0.60, 0.82) compared with men with no intake of added bran (P for trend
0.001). Added germ was not associated with CHD risk.
Conclusion: This study supports the reported beneficial association of whole-grain intake with CHD and suggests that the bran component of whole grains could be a key factor in this relation.
Key Words: Whole grains bran germ prospective population study coronary heart disease
| INTRODUCTION |
|---|
|
|
|---|
3 servings of whole-grain food items. Whole grains have a high content of nutrients that are related to beneficial health effects in observational studies. Constituents such as fiber, vitamin E, vitamin B-6, minerals, antioxidants, and phytoestrogens are found in the bran and germ components of whole grains (8). In refined-grain products, the endosperm is separated from the bran and germ before milling, which leaves these refined products relatively nutrient poor (9). Because bran and germ can easily be added to food during processing or cooking, it is important to consider whether these components contribute to the reduced CHD risk independently or whether whole-grain products yield a greater benefit than do the sum of the parts.
Currently, most epidemiologic studies have used a definition of whole-grain foods developed by Jacobs et al (1) to calculate the number of servings of whole-grain products. By this definition, a single serving of dark bread, brown rice, popcorn, wheat germ, bran, cooked oatmeal, bulgur, couscous, and breakfast cereals with a whole-grain or bran content >25% by weight are classified equally as whole-grain products. This relatively qualitative classification may have methodologic limitations because the amount of whole grain in each serving can vary considerably. Furthermore, this classification does not allow a separate analysis of the bran and germ contents of whole grains, for which the nutrient composition and health effects may differ (8, 10).
Recently, the Food and Drug Administration (FDA) approved a health claim for whole-grain foods that contain
51% whole-grain ingredients by weight per reference amount customarily consumed (RACC) (11). To date, there are no data to support the 51% cutoff as a minimum requirement nor are there data to support the exclusion of added bran or germ from this health claim. The effect of whole grains from all foods, whether the whole-grain content is < or >25% or 50% by weight, should be quantitatively the same. Also, if much of the benefit of whole grains can be attributed to particular subcomponents of the grains, such as the bran or germ, this too should be clarified.
In the Health Professionals Follow-Up Study, we developed a new whole-grain food-composition database and estimated the daily intake of whole grains (in g) from all foods and from only those foods that meet Jacobs et al's (1) and the FDA's classification criteria. We also estimated the intakes of bran and germ (in g/d), both the amounts added to foods and naturally occurring in whole grains) to evaluate the association between daily intake of whole grains, bran, and germ and CHD risk in men.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
Participants were included in the present analysis if they had <70 missing items on the 131-item FFQ and their reported daily energy intake was within the range of 800 and 4200 kcal/d at baseline. Men with prevalent cardiovascular disease, diabetes, or cancer at baseline were excluded because of possible changes in diet after diagnosis. A total of 42 850 men remained for this analysis.
Dietary assessment
Dietary information was collected with a validated semiquantitative FFQ, which was described in detail elsewhere (12, 13). Briefly, the questionnaire was designed to assess average food intakes over the previous year and included questions regarding the consumption of grain foods such as cooked and cold breakfast cereals, white and dark bread, white and brown rice, and pasta. The men were asked to specify the brand and type of cold breakfast cereal usually eaten. For each food, a commonly used unit or portion size was specified along with 9 possible response categories for frequency of intake ranging from "never" to "6 or more times per day." The FFQ included open-ended questions regarding the usual serving size and frequency of consumption of foods not listed on the FFQ. The portions were converted to gram weights per serving, and intakes of nutrients were computed by multiplying the frequency of consumption of each unit of food by the nutrient content in grams. The whole-grain content of all grain foods (rice, bread, pasta, and breakfast cereals) was determined by assigning whole-grain values according to the dry weight of whole-grain ingredients. Bran and germ values were assigned after review of the literature to determine the percentage of bran, germ, and endosperm of the different grains. The natural bran or germ corresponded to the amount that would typically be found in the type of whole grain, and the added amount was any bran or germ beyond that estimated from the natural amount.
Product labels and nutrient and ingredient information provided by General Mills Inc, Kellogg, Post, and other breakfast cereal manufacturers were used to derive the amounts of whole grain, naturally occurring bran and germ, and added bran and germ in >250 brand name cereals. Manufacturers' product information was also used to develop whole-grain profiles for commercially prepared foods, such as bran muffins. The recipe for "other cooked breakfast cereal" on the FFQ was based on "Cream of Wheat" (Kraft Foods, Parsippany, NJ) selected on the basis of marketplace shelf spacing of hot cereals. For the question on "dark bread," we used a composite of 7 types of commercially prepared bread: whole wheat, cracked wheat, wheat bran, oatmeal, whole oat, oat bran, and rye. Recipes were written for each type of bread by using product labels, and the final composite for dark bread was developed by using a weighted average based on observation of shelf space in local supermarkets. Cookbooks, such as The Joy of Cooking, were used to create recipes for home-prepared bakery items.
Whole grains were considered in their intact and pulverized forms, for which, by definition, they must contain the expected proportion of bran, endosperm, and germ for the specific grain types. The following ingredients in the database were designated as whole grains: whole wheat and whole-wheat flour, whole oats and whole-oat flour, whole cornmeal and whole-corn flour, brown rice and brown-rice flour, whole barley, whole rye and rye flour, bulgur, buckwheat, popcorn, amaranth, and psyllium. Wheat bran, corn bran, oat bran, rice bran, and wheat germ that were added to foods either during processing or by participants while cooking were considered to be added bran and germ, respectively. Intake of whole grains (in g/d) was estimated from 1) all grain foods, 2) foods with >25% whole-grain content per RACC (on a dry-weight basis), and 3) foods with
51% whole-grain content per RACC (on a dry-weight basis), both including and excluding added bran and germ. Total bran and germ consumption were estimated in a similar manner and further subdivided into their natural and added components.
The glycemic load of each food was calculated by multiplying the carbohydrate content per serving of each food item by the glycemic index value. To provide the participants' overall dietary glycemic loads, the glycemic load of the individual foods was then multiplied by the average number of servings consumed of that food per day and this was summed over all the foods (14).
Case ascertainment
Nonfatal myocardial infarction and fatal CHD occurring between 1986 and 31 January 2000 were considered as endpoints. Myocardial infarction was first identified by self-reports on biennial questionnaires and then confirmed by medical records with the use of World Health Organization criteria (15). Deaths were reported by next of kin, postal authorities, or the National Death Index. Fatal CHD was confirmed by medical records or autopsy reports. Further details of the confirmation of endpoints are published elsewhere (16).
Statistical analysis
All reported nutrient intakes (including vitamins and minerals), except alcohol, were adjusted for total energy intake by the residual method (13, 17). After energy adjustment, all nutrients, except alcohol intake and the measurements of added bran and germ, were categorized into quintiles. Because many participants did not consume supplemental bran or germ, we created a separate category of "no intake" as a reference for each, an additional 4 equal categories for "added bran intake," and 2 equal categories for intake of added germ. To reduce within-person variation and best represent long-term dietary intake, we calculated cumulative averages of food and nutrient intakes from the repeated FFQs. Because changes in diet after the development of the intermediate conditions angina, hypercholesterolemia, hypertension, and diabetes may confound the associations between diet and disease (18), dietary information was not further updated among persons reporting these conditions. Nondietary covariates were updated at each biennial follow-up.
Person-time was calculated for each participant from the date of return of the 1986 questionnaire to the date of the first CHD event, death, or 31 January 2000. Data were analyzed by means of Cox Proportional hazard regression, stratified by age (in mo). Multivariate analyses included intakes of whole grains and added bran and germ simultaneously and were further adjusted for energy intake (kcal/d in quintiles), smoking (never, past, and current smoker of <15, 1624, or >24 cigarettes/d), alcohol intake (0, 0.14.9, 5.014.9, 15.029.9, or
30 g/d), family history of myocardial infarction (yes or no), use of vitamin E supplements (yes or no), physical activity [metabolic equivalents (MET)-h/wk, in quintiles], intake of fats (saturated, polyunsaturated, and trans; g/d in quintiles), and daily servings of fish, fruit, and vegetables (quintiles). A separate inclusion of body mass index (BMI; in kg/m2) was considered because it could be both a confounder as well as a mediator. Studies have suggested that whole grains can affect body weight regulation by influencing insulin sensitivity and satiety (19). Because this potential intermediate effect of BMI on the relation between whole grains and CHD would imply a reduction in total energy, we repeated this analysis while removing total energy from the multivariate model. Categories for BMI were as follows: <21, 2122.9, 2324.9, 2526.9, 2728.9, 2930.9, and
31. In other exploratory analyses, we evaluated whether the associations for whole grains were independent of important constituents, such as dietary fiber, folate, magnesium, glycemic load, vitamins B-6 and E, and manganese by including them in the multivariate model. Furthermore, intermediate endpointssuch as diabetes, hypertension and hypercholesterolemiawere included to address potential mechanistic pathways. The association between intake of total bran and germ (total intake including both the natural bran and germ from whole grains and the bran and germ added during processing or cooking) and CHD was additionally estimated in multivariate models (without whole-grain intake in the model). To minimize residual confounding, we performed additional analyses of the association between intake of whole grain and CHD in subgroups of men who, at baseline, reported to be never smokers, to be less active (MET-h/wk < 18), to have a BMI < 25, to not have hypercholesterolemia, to not use vitamin E supplements, and to not drink alcohol.
To test the health effects of foods that qualified for the FDA whole-grain health claim, we repeated the analyses for intake of whole grains, bran, and germ only from foods with a whole-grain content
51% of dry weight. Tests of linear trends across categories of the dietary exposures were performed by assigning the medians of intakes in the categories as continuous variables. All statistical analyses were performed by using SAS program software (version 8.2; SAS Institute Inc, Cary NC).
| RESULTS |
|---|
|
|
|---|
18%, 17%, and 15%, respectively (data not shown). In Table 1
|
|
|
A large proportion (228 636 person-years) of the study population did not consume products with supplemental bran, yet among consumers the quartiles of added bran included a large variation in intake (Table 4
). Compared with nonconsumers of added bran, age-adjusted HRs among the consumers showed a strong inverse association with CHD. Additional adjustment for potential confounders only modestly attenuated this association when the top quartile was compared with nonusers (HR: 0.70; 95% CI: 0.60, 0.82; P for trend < 0.0001). Further control for BMI and whole-grain constituents did not appreciably attenuate the risk estimates.
|
|
Because men with hypercholesterolemia reported a higher intake of whole grains (Table 2
), presumably due in part to changes in diet after diagnosis, we reanalyzed the association between whole-grain intake and CHD after exclusion of the 3086 men who reported hypercholesterolemia at baseline. After exclusion of these men, the multivariate-adjusted inverse relation was similar to that presented in Table 3
. Compared with men in the bottom quintile of whole-grain intake, the multivariate-adjusted HR for CHD was 0.82 (95% CI: 0.69, 0.98) among men in the top quintile. Analyses in the other subgroups of CHD risk factors from our multivariate model showed essentially similar associations between whole-grain intake and CHD among men who were never smokers, were nondrinkers, had a BMI < 25, did not take vitamin E supplements, or had lower levels of physical activity (data not shown).
To address whether the new FDA classification of whole-grain foods (restricted to those with
51% whole-grain content per RACC) would change these results, we repeated all multivariate analyses using only foods with a whole-grain content
51% of total weight in our calculation of whole-grain intake (mean intake in fifth quintile roughly equal to mean intake in fourth quintile in analysis of whole grain from all foods). The estimates for the highest quintile of this analysis (HR: 0.88; 95% CI: 0.75, 1.03) were virtually the same as for the fourth quintile in the total whole-grain analysis (Table 3
).
| DISCUSSION |
|---|
|
|
|---|
Although we adjusted for several confounding factors, the possibility of uncontrolled confounders still remains. In general, a greater intake of whole grains and bran and germ was related to an overall healthier diet and lifestyle. A particular point of concern may be confounding by the generally high intake of dietary fiber, which has been shown to be related to a reduced risk of CHD in several prospective studies (20, 21). Participants with a high whole-grain intake in this study also consumed more dietary fiber, which was not accounted for by cereal fiber alone (Table 2
). Although we adjusted for intake of added bran, fruit, and vegetables in our multivariate analyses, residual confounding may still have been present. Additionally, more subtle behavioral and psychosocial factors related to whole-grain intake might also be important with regard to disease risk. However, the Health Professional Follow-Up Study is a relatively homogenous cohort with regard to educational attainment and socioeconomic status. We performed several stratified analyses to address concerns of residual confounding by healthy participant characteristics associated with whole-grain intake and found no discrepant results in subgroups including never smokers and nondrinkers. Furthermore, if uncontrolled confounding were to explain the inverse association between bran intake and CHD, we would expect a similar effect for germ intake, which was similarly associated with healthier lifestyles and dietary habits (data not shown). However, after the adjustment for potential confounders, germ intake was unrelated to CHD.
It is likely that some measurement error existed in our calculation of the intake of whole grains, bran, and germ (in g/d). However, any measurement error and resulting misclassification are likely to be unrelated to CHD and would thus tend to attenuate any association between these exposures and CHD.
Our results of whole-grain intake (in g/d) and CHD confirm the results of previous individual studies and meta-analyses of servings of whole-grain foods or products with a whole-grain content >25% (22). In the Atherosclerosis Risk in Communities Study, 3 daily servings of whole grain was associated with a relative risk of 0.71 (95% CI: 0.53, 0.95) for incident coronary artery disease (4) and in the Nurses' Health Study (3), the corresponding relative risk of CHD was 0.75 (95% CI: 0.59, 0.95). Jacobs et al reported associations between the same amount of whole grain and relative risks for mortality from CHD of 0.76 (95% CI: 0.56, 1.02) and 0.82 (95% CI: 0.63, 1.06) in a Norwegian cohort study (6) and in the Iowa Women's Health Study (1), respectively. In comparison, we found that the risk of CHD is reduced by
15% when the intake of whole grain is >25 g/d. As a direct comparison with these results, it can be pointed out that one serving of toasted oats provides 25 g whole grain, but such an intake could also be achieved by consuming one serving of low-fat granola with raisins and a slice of rye bread; both of these foods would not be considered to be whole grain according to the FDA definition.
Because our analyses of whole grains from all sources and only from foods that contain
51% whole-grain ingredients were similar, our results suggest that the effects of whole grains are independent of the whole-grain concentration of the food source. Thus, the beneficial effects of high intakes of whole grain can be achieved regardless of the food source. The recent FDA-approved health claim for whole-grain foods that contain
51% whole-grain ingredients by weight or the alternative definition of a 25% cutoff may be too restrictive and exclude a substantial number of helpful foods that contain whole grain but do not meet an arbitrary threshold. Labeling food products with a health claim based simply on grams of whole grain may prove a good guide for consumers who want to be efficient in their selection of foods high in whole grains.
The mechanisms by which whole grains contribute to health benefits remain to be elucidated. It is known that whole grains are a rich source of many nutrients and phytochemicals such as fiber, minerals (calcium, magnesium, potassium, phosphorous, selenium, manganese, zinc, and iron), vitamins (especially high in vitamins B and E), phenolic compounds, phytoestrogens (lignans), and related antioxidants (8). These compounds all have important biological functions, which as a whole could make an important contribution to the reduction of CHD risk. Intake of whole-grain foods and fiber-rich diets have been associated with a lower risk of obesity (23, 24) and diabetes (25, 26), an increased insulin sensitivity (27), and reduced cholesterol concentrations (28). However, results from clinical studies that specifically use whole-grain foods are both sparse and inconsistent in their reported effects on serum cholesterol (29, 30), postprandial glucose and insulin responses (3134), obesity (33), and hypertension (29). Furthermore, several of these trials were conducted among highly restrictive populations or were too short to capture the potential CHD benefits of a diet high in whole grains.
We found a strong inverse association between bran intake and CHD in this cohort of men. To our knowledge, only Liu et al (3) have addressed the independent effects of the whole-grain components and CHD. In the Nurses' Health Study, the inverse association between servings of bran and CHD was stronger than for any other grain-food item. One of the main explanations for the beneficial effects of bran intake is the high concentration of dietary fiber. Jacobs et al (35) showed that fiber from whole grains was more strongly related to a reduced risk of total cancer and CHD mortality than was fiber from refined grains. The authors suggest that the botanically linked fiber and phytochemicals in the bran could provide additional health benefits over that of fiber alone (35). In our study, adjustment for fiber and the micronutrient constituents did not have an appreciable effect on the reported inverse association between bran intake and CHD. This finding suggests that other benefits may arise from additional protective constituents in the bran or interactive effects between the constituents (9, 22). Experimental studies suggest that the effects of bran on CHD risk factors may be dependent on the food sources. Although we did not assess different sources of bran, most of the added bran consumed was derived from wheat and oats in this cohort. Oat bran is particularly linked with reduced serum cholesterol (36, 37), whereas these effects have not been reported for wheat bran (29, 32). The effect of oat bran on cholesterol suggested from clinical trials was too small to explain the reduction in risk of CHD that we found when we compared the highest with the lowest quintiles of bran intake. Additional scientific studies relating bran from different sources to CHD are warranted. If the benefit of supplemental bran is confirmed, the FDA should consider revising the health claim for whole grains to explicitly include the benefits from added bran.
In conclusion, we found an inverse relation between the intake of whole grains and bran with CHD risk in a large-scale prospective study of US male health professionals. We cannot rule out the possibility of residual confounding from reported lifestyle characteristics or the existence of an unmeasured factor associated with high intakes of whole grain being responsible for the reduction in CHD. However, given the specificity of our findings for bran and whole grains, whole grains should be considered an important modifiable risk factor for CHD, and further studies to investigate the additional benefit from the bran and germ components of whole grains are warranted.
| ACKNOWLEDGMENTS |
|---|
All authors were involved in the critical revision of the manuscript and gave final approval of the submitted manuscript. MKJ, PK-B, MF, LS, FBH, MG, and EBR contributed to the study design, analysis, and interpretation of the data. MF and LS developed the whole-grain database. MKJ drafted the manuscript. None of the authors had any conflicts of interest. The funding organizations had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, and approval of the manuscript.
| REFERENCES |
|---|
|
|
|---|
Related articles in AJCN:
This article has been cited by other articles:
![]() |
D. A. Timm and J. L. Slavin Dietary Fiber and the Relationship to Chronic Diseases American Journal of Lifestyle Medicine, June 1, 2008; 2(3): 233 - 240. [Abstract] [PDF] |
||||
![]() |
R. M van Dam and F. B Hu Are alkylresorcinols accurate biomarkers for whole grain intake? Am. J. Clinical Nutrition, April 1, 2008; 87(4): 797 - 798. [Full Text] [PDF] |
||||
![]() |
M. B. Andon and J. W. Anderson State of the Art Reviews: The Oatmeal-Cholesterol Connection: 10 Years Later American Journal of Lifestyle Medicine, February 1, 2008; 2(1): 51 - 57. [Abstract] [PDF] |
||||
![]() |
P. B Mellen, A. D Liese, J. A Tooze, M. Z Vitolins, L. E Wagenknecht, and D. M Herrington Whole-grain intake and carotid artery atherosclerosis in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1495 - 1502. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Andersson, S. Tengblad, B. Karlstrom, A. Kamal-Eldin, R. Landberg, S. Basu, P. Aman, and B. Vessby Whole-Grain Foods Do Not Affect Insulin Sensitivity or Markers of Lipid Peroxidation and Inflammation in Healthy, Moderately Overweight Subjects J. Nutr., June 1, 2007; 137(6): 1401 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hallikainen, L. Toppinen, H. Mykkanen, J. J Agren, D. E Laaksonen, T. A Miettinen, L. Niskanen, K. S Poutanen, and H. Gylling Interaction between cholesterol and glucose metabolism during dietary carbohydrate modification in subjects with the metabolic syndrome Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1385 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bo, M. Durazzo, S. Guidi, M. Carello, C. Sacerdote, B. Silli, R. Rosato, M. Cassader, L. Gentile, and G. Pagano Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1062 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Brock, C. K. Davis, B. A. Irving, J. Rodriguez, E. J. Barrett, A. Weltman, A. G. Taylor, and G. A. Gaesser A High-Carbohydrate, High-Fiber Meal Improves Endothelial Function in Adults With the Metabolic Syndrome Diabetes Care, October 1, 2006; 29(10): 2313 - 2315. [Full Text] [PDF] |
||||
![]() |
J. A Nettleton, L. M Steffen, E. J Mayer-Davis, N. S Jenny, R. Jiang, D. M Herrington, and D. R Jacobs Jr Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA) Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1369 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K Jensen, P. Koh-Banerjee, M. Franz, L. Sampson, M. Gronbaek, and E. B Rimm Whole grains, bran, and germ in relation to homocysteine and markers of glycemic control, lipids, and inflammation 1 Am. J. Clinical Nutrition, February 1, 2006; 83(2): 275 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Qi, R. M. van Dam, S. Liu, M. Franz, C. Mantzoros, and F. B. Hu Whole-Grain, Bran, and Cereal Fiber Intakes and Markers of Systemic Inflammation in Diabetic Women Diabetes Care, February 1, 2006; 29(2): 207 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E Laaksonen, L. K Toppinen, K. S Juntunen, K. Autio, K.-H. Liukkonen, K. S Poutanen, L. Niskanen, and H. M Mykkanen Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1218 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W Anderson Whole grains and coronary heart disease: the whole kernel of truth Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1459 - 1460. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |